Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DXHB1S
|
||||
Drug Name |
2-(N-Methyl-guanidino)-N-[3-methyl-5-sulfamoyl-3H-[1,3,4]thiadiazol-(2E)-ylidene]-acetamide
|
||||
Synonyms |
CHEMBL333692
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C7H13N7O3S2
|
||||
Canonical SMILES |
CN(CC(=O)\\N=C/1\\SC(=NN1C)S(=O)(=O)N)C(=N)N
|
||||
InChI |
InChI=1S/C7H13N7O3S2/c1-13(5(8)9)3-4(15)11-6-14(2)12-7(18-6)19(10,16)17/h3H2,1-2H3,(H3,8,9)(H2,10,16,17)/b11-6+
|
||||
InChIKey |
FCHMBSURKDQMKR-IZZDOVSWSA-N
|
||||
Target and Pathway | |||||
Target(s) | Carbonic anhydrase II | Target Info | [1587926] | ||
Carbonic anhydrase I | Target Info | [1587926] | |||
NetPath Pathway | IL4 Signaling Pathway | ||||
EGFR1 Signaling Pathway | |||||
Pathway Interaction Database | C-MYB transcription factor network | ||||
PathWhiz Pathway | Gastric Acid Production | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.